Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18199067 | 0.97 | TSHR (0.33) | TSHRMEN1CYP1A2MAPTCYP2C9 | |
| SCHEMBL18199061 | 0.89 | TSHR (0.34) | TSHRMEN1CYP1A2MAPTCYP2C9 | |
| SCHEMBL18199066 | 0.81 | TSHR (0.32) | TSHR | |
| SCHEMBL18199059 | 0.80 | TSHR (0.32) | TSHR | |
| SCHEMBL5485323 | 0.79 | GPR3 (0.36) | MEN1CYP1A2CYP2C9KMT2AKEAP1 | |
| SCHEMBL14094067 | 0.76 | PARP1 (0.34) | TSHRMEN1CYP1A2MAPTCYP2C9 | |
| SCHEMBL18199074 | 0.73 | — | — | |
| SCHEMBL18202308 | 0.72 | GPR3 (0.40) | TSHRMEN1CYP1A2MAPTCYP2C9 | |
| SCHEMBL18199068 | 0.70 | — | — | |
| SCHEMBL18202307 | 0.67 | KEAP1 (0.33) | TSHRMEN1CYP1A2MAPTCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160322667-A1 | CYCLIC SULFONIC ACID ESTER COMPOUND, NON-AQUEOUS ELECTROLYTE SOLUTION, AND LITHIUM ION SECONDARY BATTERY USING SAME | NEC CORPORATION (JP) | 2016-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160322667-A1 | CYCLIC SULFONIC ACID ESTER COMPOUND, NON-AQUEOUS ELECTROLYTE SOLUTION, AND LITHIUM ION SECONDARY BATTERY USING SAME | CA1, ASIC1, SLC9A1 | TSHR 1361/4885MEN1 2015/4885CYP1A2 2708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.